Rajnath Singh Releases DRDO’s First Batch of Anti-COVID Oral 2-Deoxy-D-Glucose, Details Inside


The first batch of the anti-COVID 2-DG (2-deoxy-D-glucose) drug developed by DRDO was launched on Monday to treat patients with the deadly disease. The medicine is in powder form and can be taken with water.

Defense Minister Rajnath Singh and Health Minister Harsh Vardhan have released the first batch of 2-DG, an anti-Covid-19 therapeutic application of the drug developed by the Institute of Nuclear Medicine and Allied Sciences (INMAS) , a Defense Research and Development Organization (DRDO) laboratory in collaboration with Dr Reddy’s Laboratories (DRL).

ALSO READ  UAE extends suspension of flights from India until June 30 to curb spread of virus

Rajnath Singh handed over the anti-COVID drug to his cabinet colleague Harsh Vardhan who handed it over to the director of the Indian Institute of Medical Sciences in Delhi (AIIMS), Randeep Guleria, at an event here.